Nemes Rush Group LLC Novo Cure LTD Transaction History
Nemes Rush Group LLC
- $728 Billion
- Q2 2024
A detailed history of Nemes Rush Group LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Nemes Rush Group LLC holds 60 shares of NVCR stock, worth $1,113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 60
-0.0%
Holding current value
$1,113
Previous $938,000
9.59%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$225 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$217 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$207 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$55.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$44.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.95B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...